5AM Ventures VI, L.P.
CIK: 0001753037
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LTGO
Latigo Biotherapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About 5AM Ventures VI, L.P.
5AM Ventures VI, L.P. (SEC CIK 0001753037) files insider reports with the SEC as 10% Owner of Latigo Biotherapeutics, Inc. (LTGO).
Signal8 holds 2 ownership filings by 5AM Ventures VI, L.P. (1 Form 3, 1 Form 4), filed between Aug 6, 2026 and Aug 12, 2026. Those filings report 2 transactions, the latest on Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on 5AM Ventures VI, L.P.'s filings is in SAN FRANCISCO, CA.
Recent filings by 5AM Ventures VI, L.P.
- Aug 10, 2026: Conversions of LTGO shares (2 lines, Form 4, code C).
Other insiders filing for Latigo Biotherapeutics, Inc. (LTGO)
- Sanofi, 10% Owner
- Westlake BioPartners Fund I, L.P., 10% Owner
- Foresite Capital Management V, LLC, 10% Owner
- SMITH TODD N, Director
- Tananbaum James B., Director
- SEIDENBERG BETH C, Director